PubMed COVID-19 Clinical Care

CONCLUSION: A larger number of total symptoms and specifically "whole body"/systemic symptoms during the acute phase of SARS-CoV-2 infection in athletes is associated with prolonged RTFP.

COVID-19 vaccine decisions are shaped by many factors including historical and contemporary patterns of medical mistreatment of marginalized communities. In attending to these concerns, we measured whether fear of COVID-19, general feelings of

The Covid-19 pandemic has had a universal impact on humanity. All patients in the European health systems have experienced digital healthcare in some way. Digital technologies were deployed during the pandemic in various areas of the health care

The COVID-19 pandemic underlined that communities are key in sharing trusted, timely and relevant information especially during a health emergency where the overabundance of information makes it difficult to make decisions to protect one's health

CONCLUSION: cf-mtDNA is probably important in the outcome of SARS-CoV-2 infection due to its role in inflammation and immune response. It can also be a promising candidate biomarker for the diagnosis of COVID-19 subgroups. Further investigation will

CONCLUSION: Elucidating the risk factors for and common pathogens of BSI can inform prompt management and prevention of BSIs.

CONCLUSION: during the SARS-CoV-2 epidemic in Zambia, most deaths occurred in the community, indicating potential gaps in public health messaging about COVID-19. Improving health-seeking behaviors for COVID-19 through public messaging campaigns and

The latest public health emergencies exposed urgent gaps in health promotion, prevention and preparedness (HPPP). Existing and new infectious diseases have gained far more prevalence than expected, and inequities in access to health care accounted

CONCLUSION: Our study highlights a novel nanobody, Nb-H6, that may be useful therapeutically in SARS-CoV-2 and VOC outbreaks and pandemics. These findings also provide a molecular foundation for further studies into how nanobodies neutralize SARS-CoV

CONCLUSIONS: FNC emerges as a feasible treatment against the Omicron BA.5.1.3 subvariant. It may reduce ICU stay and demonstrate a promising safety profile without major side effects or disruption to normal physiological parameters.